ECM
SEEL

ETrade Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

ETrade Capital Management’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$13K Buy
4
+1
+33% +$3.59K ﹤0.01% 877
2020
Q2 		$10K Buy
+3
New +$9.96K ﹤0.01% 840

Other funds holding SEEL

UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ETrade Capital Management's SEEL Position: Q3 2020 in Review

ETrade Capital Management increased its Seelos Therapeutics, Inc. Common Stock (SEEL) stake by 33% in Q3 2020, buying an estimated $3.59K and bringing the position to 4 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #877.

ETrade Capital Management first reported a position in SEEL in Q2 2020 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold SEEL as of Q3 2020.

  • ETrade Capital Management held 4 shares of Seelos Therapeutics, Inc. Common Stock worth $13K as of Q3 2020.
  • ETrade Capital Management bought 1 Seelos Therapeutics, Inc. Common Stock share in Q3 2020, an estimated $3.59K.
  • Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of ETrade Capital Management's portfolio in Q3 2020, its #877 holding.
  • ETrade Capital Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.